Amount of fentanyl needed intraoperative and postoperative after extubation, and every hour postoperative for four hours.
Ketamine Versus Morphine Change Pain Profile
Brief Summary
Intervention / Treatment
-
Ketamine (DRUG)Ketamine group to whom intravenous ketamine was administered in a loading dose of 0.15 mg/kg over 5 min, 10 minutes pre incision, followed-by an infusion at 2 micg/kg/min until the end of surgery.
-
Morphine (DRUG)a loading dose of 0.1 mg/kg over 20 min intravenously, 10 minutes pre incision, then infused with morphine an infusion rate of 5 - 40 microgram/kg/hour till the end of surgery.
Condition or Disease
- Acute Pain
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Completed |
Study results: | No Results Available |
Age: | 18 Years to 50 Years |
Enrollment: | 160 (ACTUAL) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Treatment |
MaskingTRIPLE:
|
Clinical Trial Dates
Start date: | Sep 15, 2018 | ACTUAL |
---|---|---|
Primary Completion: | Dec 31, 2019 | ACTUAL |
Completion Date: | Jan 20, 2020 | ACTUAL |
Study First Posted: | Sep 10, 2018 | ACTUAL |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Jun 26, 2020 |
Sponsors / Collaborators
Location
Participant Groups
-
patients with a ketamine infusion intraoperative
-
patients with a Morphine infusion intraoperative
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 18 |
Maximum Age: | 50 |
Age Groups: | Adult |
Healthy Volunteers: | Yes |
* ASA physical status I or II
* patients aged between 18-50 years old. -
Exclusion Criteria:
* those who refused to participate
* ASA physical status III, IV, patients younger than 18 years or older than 50 years old
* super morbid obesity with BMI 50, history of epilepsy
* patients having a history of parenteral or oral analgesics within the last 24 hours before
* initiation of operation
* those having an allergy to study agents.
Primary Outcomes
Secondary Outcomes
-
Visual analogue scale for pain assessment.( VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (symptom,pain,health) orientated from the left (worst) to the right (best). In some studies,horizontal scales are orientated from right to left ,and many investigators use vertical VAS.The most simple VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (symptom,pain,health) orientated from the left (worst) to the right (best). In some studies,horizontal scales are orientated from right to left .
Other Outcomes
-
Anxious agitated and restless= 1 point * Cooperative, oriented and tranquil= 2 points * Responding only to verbal commands= 3 points * Brisk response to light glabella tap or loud auditory stimulus= 4points * Sluggish response to light glabella tap or loud auditory response= 5 points * No response to light glabella tap or loud auditory response= 6 points
More Details
NCT Number: | NCT03664622 |
---|---|
Other IDs: | wahdan kteamine |
Study URL: | https://clinicaltrials.gov/study/NCT03664622 |